Showing results (671-680 of 690) with videos related to

Sort By:
Pageof 69
Journal of Hematology & Oncology|March 20, 2019
Early myeloid-derived suppressor cells (HLA-DR-/lowCD33+CD16-) expanded by granulocyte colony-stimulating factor prevent acute graft-versus-host disease (GVHD) in humanized mouse and might contribute to lower GVHD in patients post allo-HSCTKe Wang, Meng Lv, Ying-Jun Chang, et al.
Frontiers in Oncology|January 24, 2022
Preemptive Immunotherapy for Minimal Residual Disease in Patients With t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell TransplantationShuang Fan, Meng-Zhu Shen, Xiao-Hui Zhang, et al.
Biomolecules & Biomedicine|May 15, 2023
CSRP2 transcript levels after consolidation therapy increase prognostic prediction ability in B-cell acute lymphoblastic leukaemiaLei-Ming Cao, Ya-Lan Zhou, Robert Peter Gale, et al.
Innovation (Cambridge (Mass.))|March 18, 2025
Manipulation of a strigolactone transporter in tomato confers resistance to the parasitic weed broomrapeXinwei Ban, Li Qin, Jijun Yan, et al.
Nature Metabolism|October 6, 2022
Microglial hexokinase 2 deficiency increases ATP generation through lipid metabolism leading to β-amyloid clearanceLige Leng, Ziqi Yuan, Ruiyuan Pan, et al.
Nature Aging|December 19, 2025
CDK3 induces neuronal death and brain atrophy in Alzheimer's diseaseKai Zhuang, Liu Zi, Xiao Su, et al.
BMC Cancer|March 20, 2021
Wilms' tumor gene 1 is an independent prognostic factor for pediatric acute myeloid leukemia following allogeneic hematopoietic stem cell transplantationDao-Xing Deng, Juan-Juan Wen, Yi-Fei Cheng, et al.
JCI Insight|January 6, 2022
Donor NKG2C homozygosity contributes to CMV clearance after haploidentical transplantationXing-Xing Yu, Qian-Nan Shang, Xue-Fei Liu, et al.
Chinese Medical Journal|December 5, 2018
Association of Persistent Minimal Residual Disease with Poor Outcomes of Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell TransplantationJing Liu, Xiao-Su Zhao, Yan-Rong Liu, et al.
American Journal of Hematology|January 26, 2019
Minimal residual disease status determined by multiparametric flow cytometry pretransplantation predicts the outcome of patients with ALL receiving unmanipulated haploidentical allograftsXiao-Su Zhao, Yan-Rong Liu, Lan-Ping Xu, et al.
Pageof 69